Early Complete Revascularization in Hemodynamically Stable Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease

被引:9
|
作者
Fortuni, Federico [1 ,2 ,3 ]
Crimi, Gabriele [4 ]
Angelini, Filippo [5 ]
Leonardi, Sergio [1 ,2 ,3 ]
D'Ascenzo, Fabrizio [5 ]
Ferlini, Marco [4 ]
Rolando, Marco [1 ,2 ,3 ]
Raisaro, Arturo [4 ]
Visconti, Luigi Oltrona [4 ]
Ferrario, Maurizio [4 ]
Gnecchi, Massimiliano [1 ,2 ,3 ]
De Ferrari, Gaetano M. [1 ,2 ,3 ]
机构
[1] Fdn IRCCS Policlin San Matte, Coronary Care Unit, Pavia, Italy
[2] Fdn IRCCS Policlin San Matte, Lab Clin & Expt Cardiol, Pavia, Italy
[3] Univ Pavia, Dept Mol Med, Pavia, Italy
[4] Fdn IRCCS Policlin San Matte, Div Cardiol, Piazzale Golgi 1, I-27100 Pavia, Italy
[5] Univ Torino, ChM Salute & Sci Hosp, Div Cardiol, Turin, Italy
关键词
PERCUTANEOUS CORONARY INTERVENTION; CULPRIT-ONLY REVASCULARIZATION; 2011 ACCF/AHA/SCAI GUIDELINE; ARTERY-DISEASE; RANDOMIZED-TRIAL; FOCUSED UPDATE; TASK-FORCE; MANAGEMENT; VESSEL; METAANALYSIS;
D O I
10.1016/j.cjca.2019.03.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The optimal strategy and timing of revascularization in hemodynamically stable patients with ST-segment elevation myocardial infarction and multivessel disease is unknown. We performed a systematic review and meta-analysis to explore the comparative efficacy and safety of early complete revascularization vs culprit-only or staged revascularization in this setting. Methods: We searched the literature for randomized clinical trials that assessed this issue. Early complete revascularization was defined as a complete revascularization achieved during the index procedure or within 72 hours. Efficacy outcomes were major adverse cardiovascular events, myocardial infarction, repeat revascularization, and all-cause mortality. Safety outcomes were all bleeding events, stroke, and contrast-induced acute kidney injury. Results: Nine randomized clinical trials with a total of 2837 patients were included; 1254 received early complete revascularization and 1583 were treated with other revascularization strategies. After a mean follow-up of 15.3 +/- 9.4 months early complete revascularization was associated with a lower risk of major adverse cardiovascular events (relative risk [RR], 0.51; 95% confidence interval [CI], 0.41-0.62; P < 0.00001; number needed to treat = 8), myocardial infarction (RR, 0.59; 95% CI, 0.40-0.87), and repeat revascularization (RR, 0.39; 95% CI, 0.28-0.55) without any difference in all-cause mortality and in safety outcomes compared with culprit-only or staged revascularization. Moreover, fractional flow reserve-guided complete revascularization reduced the incidence of repeat revascularization compared with angiography-guided procedure (chi(2) = 4.36; P = 0.04). Conclusions: Early complete revascularization should be considered in hemodynamically stable patients with ST-segment elevation myocardial infarction and multivessel disease deemed suitable for percutaneous interventions. Fractional flow reserve-guided complete revascularization might be superior to angiography-guided procedures in reducing need for further interventions.
引用
收藏
页码:1047 / 1057
页数:11
相关论文
共 50 条
  • [21] Long-term outcomes of in-hospital staged revascularization versus culprit-only intervention for patients with ST-segment elevation myocardial infarction and multivessel disease
    Cui, Kongyong
    Lyu, Shuzheng
    Song, Xiantao
    Liu, Hong
    Yuan, Fei
    Xu, Feng
    Zhang, Min
    Wang, Wei
    Zhang, Mingduo
    Zhang, Dongfeng
    Dai, Jing
    Tian, Jinfan
    CORONARY ARTERY DISEASE, 2019, 30 (03) : 188 - 195
  • [22] Revascularization strategies in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: urgent or staged?
    Cubero-Gallego, Hector
    Romaguera, Rafael
    Ariza-Sole, Albert
    Gomez-Hospital, Joan Antoni
    Cequier, Angel
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2017, 7 : S82 - S85
  • [23] Complete versus culprit-only revascularization in ST-elevation myocardial infarction and multivessel disease
    Di Pasquale, Giuseppe
    Filippini, Elisa
    Pavesi, Pier Camillo
    Tortorici, Gianfranco
    Casella, Gianni
    Sangiorgio, Pietro
    INTERNAL AND EMERGENCY MEDICINE, 2016, 11 (04) : 499 - 506
  • [24] The effect of complete revascularization in patients with ST-segment elevation myocardial infarction with Killip class ≥ III
    Lee, Wei-Chieh
    Chen, Tien-Yu
    Chen, Chien-Jen
    Yang, Cheng-Hsu
    Fang, Chih-Yuan
    Wu, Chiung-Jen
    Fang, Hsiu-Yu
    CORONARY ARTERY DISEASE, 2020, 31 (01) : 13 - 19
  • [25] Complete revascularization for patients with multivessel coronary artery disease and ST-segment elevation myocardial infarction after the COMPLETE trial: A meta-analysis of randomized controlled trials
    Bajraktari, Gani
    Bytyci, Ibadete
    Henein, Michael Y.
    Alfonso, Fernando
    Ahmed, Ali
    Jashari, Haki
    Bhatt, Deepak L.
    IJC HEART & VASCULATURE, 2020, 29
  • [26] Benefit of a staged in-hospital revascularization strategy in hemodynamically stable patients withST-segment elevation myocardial infarction and multivessel disease: Analyses by risk stratification
    Kim, Min Chul
    Bae, SungA
    Ahn, Youngkeun
    Sim, Doo Sun
    Hong, Young Joon
    Kim, Ju Han
    Jeong, Myung Ho
    Kim, Hyo-Soo
    Chae, Shung Chull
    Cha, Kwang Soo
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2021, 97 (06) : 1151 - 1159
  • [27] Nomogram to Predict Outcomes After Staged Revascularization in ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease
    Wang, Huaigen
    Ma, Aiqun
    Wang, Tingzhong
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2024, 17 : 1713 - 1722
  • [28] The optimal percutaneous coronary intervention strategy for patients with ST-segment elevation myocardial infarction and multivessel disease: a pairwise and network meta-analysis
    Hu, Meng-Jin
    Tan, Jiang-Shan
    Jiang, Wen-Yang
    Gao, Xiao-Jin
    Yang, Yue-Jin
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2022, 13
  • [29] Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction COMPLETE Trial
    Wood, David A.
    Cairns, John A.
    Wang, Jia
    Mehran, Roxana
    Storey, Robert F.
    Nguyen, Helen
    Meeks, Brandi
    Kunadian, Vijay
    Tanguay, Jean-Francois
    Kim, Hahn-Ho
    Cheema, Asim
    Deghani, Payam
    Natarajan, Madhu K.
    Jolly, Sanjit S.
    Amerena, John
    Keltai, Matyas
    James, Stefan
    Hlinomaz, Ota
    Niemela, Kari
    AlHabib, Khalid
    Lewis, Basil S.
    Nguyen, Michel
    Sarma, Jaydeep
    Dzavik, Vladimir
    Della Siega, Anthony
    Mehta, Shamir R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (22) : 2713 - 2723
  • [30] Immediate complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease treated by primary percutaneous coronary intervention: Insights from the ORBI registry
    Pimor, Anna
    Auffret, Vincent
    Didier, Romain
    Delaunay, Regis
    Filippi, Emmanuelle
    Hacot, Jean-Philippe
    Saouli, Djamel
    Rouault, Gilles
    Druelles, Philippe
    Bot, Emilie
    Coudert, Isabelle
    Boulanger, Bertrand
    Le Guellec, Marielle
    Boulmier, Dominique
    Leurent, Guillaume
    Bedossa, Marc
    Gilard, Martine
    Le Breton, Herve
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2018, 111 (11) : 656 - 665